Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats
- PMID: 1658629
- PMCID: PMC361815
- DOI: 10.1128/mcb.11.12.6268-6278.1991
Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats
Abstract
The 20-member family of 30-bp tandem repeats located within the oriP region of Epstein-Barr virus (EBV) can act as a transcriptional enhancer in the presence of EBV nuclear antigen 1 (EBNA-1). A replication fork barrier and a termination site of plasmid replication in human B cells is also found within or near the EBV tandem repeats. Within each tandem repeat is a consensus binding sequence for the EBNA-1 protein that is required for extrachromosomal maintenance of oriP-containing plasmids. To investigate the factors that contribute to the arrest of replication forks and termination in the region of the family of repeats, we have used an in vitro replication system in which replication of EBV recombinant plasmids is initiated from the simian virus 40 (SV40) DNA replication origin in the presence of SV40 T antigen and soluble extracts prepared from human cells. The system can support bidirectional replication, initiating from the SV40 DNA origin with termination occurring in a region opposite the origin. Using two-dimensional agarose gel electrophoresis, we observed a barrier to replication forks in the presence of EBNA-1 in the region of the EBV repeats. Termination occurs at or near the tandem repeats in a manner similar to that observed in vivo (T.A. Gahn and C.L. Schildkraut, Cell 58:527-535, 1989). Reducing the number of repeats from 20 to 6 had little effect on the strength of the replication fork barrier. In the absence of EBNA-1, replication forks also arrested at the EBV repeats, but at a much lower efficiency. The addition of competitor DNA containing the EBV family of repeats can almost completely abolish the replication barrier produced in the presence of EBNA-1.
Similar articles
-
Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication.J Virol. 1993 Mar;67(3):1739-45. doi: 10.1128/JVI.67.3.1739-1745.1993. J Virol. 1993. PMID: 8382320 Free PMC article.
-
Interaction of Epstein-Barr viral (EBV) origin of replication (oriP) with EBNA-1 and cellular anti-EBNA-1 proteins.Virology. 1990 Sep;178(1):293-6. doi: 10.1016/0042-6822(90)90407-i. Virology. 1990. PMID: 2167556
-
Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.J Virol. 1994 Mar;68(3):1913-25. doi: 10.1128/JVI.68.3.1913-1925.1994. J Virol. 1994. PMID: 8107251 Free PMC article.
-
Immortalizing genes of Epstein-Barr virus.Adv Virus Res. 1991;40:19-55. doi: 10.1016/s0065-3527(08)60276-6. Adv Virus Res. 1991. PMID: 1659776 Review.
-
Replication licensing of the EBV oriP minichromosome.Curr Top Microbiol Immunol. 2001;258:13-33. doi: 10.1007/978-3-642-56515-1_2. Curr Top Microbiol Immunol. 2001. PMID: 11443858 Review.
Cited by
-
Keeping it quiet: chromatin control of gammaherpesvirus latency.Nat Rev Microbiol. 2013 Dec;11(12):863-75. doi: 10.1038/nrmicro3135. Epub 2013 Nov 6. Nat Rev Microbiol. 2013. PMID: 24192651 Free PMC article. Review.
-
Plasmid maintenance of derivatives of oriP of Epstein-Barr virus.J Virol. 1995 Feb;69(2):1280-3. doi: 10.1128/JVI.69.2.1280-1283.1995. J Virol. 1995. PMID: 7815506 Free PMC article.
-
Evolutionary effects of the AID/APOBEC family of mutagenic enzymes on human gamma-herpesviruses.Virus Evol. 2019 Feb 11;5(1):vey040. doi: 10.1093/ve/vey040. eCollection 2019 Jan. Virus Evol. 2019. PMID: 30792902 Free PMC article.
-
Analysis of DNA topology of EBV minichromosomes in HEK 293 cells.PLoS One. 2017 Nov 29;12(11):e0188172. doi: 10.1371/journal.pone.0188172. eCollection 2017. PLoS One. 2017. PMID: 29186176 Free PMC article.
-
The Epstein-Barr Virus EBNA1 Protein.Scientifica (Cairo). 2012;2012:438204. doi: 10.6064/2012/438204. Epub 2012 Dec 19. Scientifica (Cairo). 2012. PMID: 24278697 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources